Theranostic Nanoparticles for Non-Invasive Brain Delivery of Therapy

Theranostic nanoparticles that cross the BBB A critical problem in the treatment of neurodegenerative disorders and diseases such as Alzheimer’s and Parkinson’s is the incapability to overcome the restrictive mechanism of the blood-brain barrier (BBB) and deliver important therapeutic agents to the brain. Our lab develops unique nanoparticles that can effectively cross the BBB.

Website design and development: WebMeUp